Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1988-07-12
1990-10-02
Schenkman, Leonard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514376, 514452, 514467, 514470, 514947, A61K 3142, A61K 31535
Patent
active
049607715
ABSTRACT:
Compositions for carrying physiologically active agents through body membranes having the structural formula I: ##STR1## where: R=H, Alkyl group containing from 1-18 carbon atoms, cycloalkyl, aryl, aralkyl, alkoxy, hydroxyalkyl, alkoyloxyalkyl, acyloxyalkyl and alkoxyalkyl;
REFERENCES:
patent: 2909467 (1959-10-01), Shapiro
patent: 4405616 (1983-09-01), Rajadhyaksha
patent: 4423040 (1983-12-01), Rajadhyaksha
patent: 4594243 (1986-06-01), Satoh et al.
Catalog Handbook of Fine Chemicals 1988-1989, p. 609, Aldrich Chemical Company, Milwaukee, Wisconsin.
Stoughton et al., pp. 737-739, Development Drug and Industrial Pharmacy, 9(4), 725-744 (1983).
Woodford and Barry, pp. 170-172, J. Toxicol.-Cut. & Ocular Toxicol. 5(3), 167-177 (1986).
Gummer, P. 566 in Percutaneous Absorption Mechanism-Methodolgy--Drug Delivery, Ed. Bronaugh and Maibach, chapter 43, 561-571, Marcel Dekker, 1985.
Transdermal Delivery of Drugs, p. 76, vol. II, Ed. Kydonieus and Berner, CRC Press Inc., Boca Raton, Florida, 1987.
Barry in Dermatological Formulations, Barry, pp. 160-172, Marcel Dekker, New York, 1983.
Hubbard Grant L.
Schenkman Leonard
LandOfFree
Oxazolidinone penetration enhancing compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oxazolidinone penetration enhancing compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oxazolidinone penetration enhancing compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-292620